Introducing a novel and robust technique for determining lymph node status in colorectal cancer

Annals of Surgery

Volumn 260, Issue 1, 2014, Pages 94-102

  Hogan, John ^a   Judge, Conor ^a   O'Callaghan, Michael ^a   Aziz, Amir ^a   O'Connor, Cormac ^a   Burke, John ^a   Dunne, Colum ^b   Walsh, Stewart ^a,b   Kalady, Matthew ^c   Coffey, J Calvin ^a,b  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

colorectal cancer; consensus profiles; lymph node metastasis; public gene expression repositories; survival

Indexed keywords

BONE MORPHOGENETIC PROTEIN; COL8A1 PROTEIN; PROTEIN KINASE FYN; SMAD PROTEIN; UNCLASSIFIED DRUG; WNT5A PROTEIN;

AREA UNDER THE CURVE; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CLASSIFIER; COLORECTAL CANCER; CONSENSUS; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

BIOPSY; COLORECTAL NEOPLASMS; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; PROGNOSIS; ROC CURVE;

EID: 84902245286     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000289     Document Type: Article

References (43)

1. Canna K, Hilmy M, McMillan DC, et al. The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Colorectal Dis. 2008;10:663-667.
2. Kang J, HurH, Soh Min B, et al. Prognostic impact of inferior mesenteric artery lymph node metastasis in colorectal cancer. Ann SurgOncol. 2011;18:704-710.
3. Kim TH, Chang HJ, Kim DY, et al. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys. 2010;77:1158-1165.
4. Hashiguchi Y, Hase K, Ueno H, et al. Prognostic significance of the number of lymph nodes examined in colon cancer surgery: clinical application beyond simple measurement. Ann Surg. 2010;251:872-881.
5. Sarmiento R, Longo R, Gasparini G. Antiangiogenic therapy of colorectal cancer: state of the art, challenges and new approaches. Int J Biol Markers. 2012;27:286-294.
6. Blake H, Dighe S, Koh MD, et al. Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer. Br J Surg. 2010;97:1407-1415.
7. Hogan et al Annals of Surgery Volume 260, Number 1, July 2014
8. Dighe S, Swift I, Magil L, et al. Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience. Colorectal Dis. 2012;14:438-444.
9. Junginger T, Hermanek P, Oberholzer K, et al. Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication. Zentralbl Chir. 2006;131:275-284.
10. Kwak JY, Kim JS, Kim HJ, et al. Diagnositc value of FDG-PET/CT for lymph node metastasis of colorectal cancer. World J Surg. 2012;36:1898-1905.
11. Dighe S, Purkayastha S, Swift L, et al. Diagnostic precision of CT in local staging of colon cancers: a meta-analysis. Clin Radiol. 2010;65:708-719.
12. Lim M, Hussain Z, Howe A, et al. The oncological outcome after right hemicolectomy and accuracy of CT scan as a preoperative tool for staging in right sided colonic cancers. Colorectal Dis. 2012;15:536-543.
13. Iafrate F, Laghi A, Paolantonio P, et al. Preoperative staging of rectal cancer with MR imaging: correlation with surgical and histopathologic findings. Radiography. 2006;26:701-714.
14. Yeung JM, Ferris NJ, Lynch AC, et al. Preoperative staging of rectal cancer. Future Oncol. 2009;5:1295-1306.
15. Van'tVeer LJ,Dai H, van deVijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530-536.
16. Carole LY, Berndt ML. Review of the literature examining the correlation among DNA microarray technologies. Environ Mol Mutagen. 2007;48:380-394.
17. Barrier A, Boelle PY, Roser F, et al. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol. 2006;24:4685-4691.
18. Barrier A, Roser F, Boelle PY, et al. Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene. 2007;26: 2642-2648.
19. Tillinghast GW. Microarrays in the clinic. Nat Biotechnol. 2011;57:688-690.
20. Shi L, Shi L, Reid L, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006;24:1151-1161.
21. Edgar R, Domrachev M, Lash A. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001;30:207-210.
22. Ikeo K, Isji-i J, Tamura T, et al. CIBEX: center for information biology gene expression database. C R Biol. 2003;326:1079-1082.
23. Brazma A, Parkinson H, Sarkans U, et al. ArrayExpress-a public repository formicroarray gene expression data at the EBI. Nucleic Acids Res. 2001;31:68-71.
24. Sherlock G, Hernandez-Boussard T, Kasarskis A, et al. The StanfordMicroarray Database. Nucleic Acids Res. 2003;29:152-155.
25. Jorissen RN, Gibbs P, Christie M, et al.Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer. Clin Cancer Res. 2009;15:7642-7651.
26. Brazma A, Hingamp P, Quackenbush J, et al. Minimum Information About a Microarray Experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001;29:365-371.
27. Groene J, Mansmann U, Meister R, et al. Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III. Int J Cancer. 2006;119:1829-1836.
28. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
29. O'Connell MJ, Lavery I, Yothers G, et al. Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. J Clin Oncol. 2010;28:3937-3944.
30. Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology. 2004;232:773-783.
31. Mao S, Wang C, Dong G. Evaluation of inter-laboratory and cross-platform concordance of DNA microarrays through discriminating genes and classifier transferability. J Bioinform Comput Biol. 2009;7:157-173.
32. Leek JT, Scharpf RB, Bravo HC, et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet. 2010;11:733-739.
33. Barnes M, Freudenberg J, Thompson S, et al. Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression. Nucleic Acids Res. 2005;33:5915-5923.
34. Lu YY, Chen JH, Ding JH, et al. A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT. Nucl Med Commun. 2012;33:1127-1133.
35. Morson BC, Whiteway JE, Jones EA. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut. 1984;25:437-444.
36. Smith J, Hwang H, Wiseman KW, et al. Ex vivo sentinel node mapping in colon cancer: improving the accuracy of pathological staging. Am J Surg. 2006;191:665-668.
37. Stojadinovic A, Nissan A, Protic M, et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United StatesMilitary Cancer Institute Clinical Trials Group Study GI-01. Ann Surg. 2007;245:846-857.
38. Kelder W, Van Der Berg A, Van Der Leij J, et al. RT-PCR and immunohistochemical evaluation of sentinel nodes after in vivo mapping with patent blue V in colon cancer patients. Scand J Gastroenterol. 2006;41:1073-1078.
39. Calvano S, Xiao W, Richards D, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032-1037.
40. Baillat G, Siret C, Delamarre E, et al. Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-independent Akt signaling in SW480 colon cancer cells. Biochim Biophys Acta. 2008;1783:2323-2331.
41. Lourenco G, Cardossa-Filho C, Goncales N, et al. A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene. Breast Cancer Res Treat. 2006;100:335-338.
42. Hwang K, Chung J, Jung M, et al. COL18A1 gene for the prognostic marker of breast cancer according to the analysis of the DNA copy number variation by array CGH. J Breast Cancer. 2010;13:37-45.
43. Salzberg SL. Genome re-annotation: awiki solution. Genome Biol. 2007;8:102.